Sanofi terminates deal on drug license after US FTC objects
WASHINGTON (Reuters) – Sanofi said on Monday it was terminating a deal to exclusively license a drug that Maze Therapeutics is developing to treat Pompe …
sanofi
Sanofi to explore acquisition of cancer drugmaker Mirati- Bloomberg News
(Reuters) – Paris-based drugmaker Sanofi is exploring a potential acquisition of cancer drugmaker Mirati Therapeutics, Bloomberg News reported on Thursday citing people familiar with the …
Sanofi lifts earnings outlook on new drug launches, Dupixent sales
By Ludwig Burger (Reuters) -French drugmaker Sanofi on Friday increased its guidance for full-year earnings, citing strong sales of anti-inflammatory treatment Dupixent and closely-watched new …
Amgen emerges frontrunner in Horizon deal as Sanofi drops bid
(Reuters) -Amgen Inc is in advanced talks to buy biotech company Horizon Therapeutics Plc, the Wall Street Journal reported on Sunday, while rival bidder French …
Sanofi and Regeneron present more positive data for Dupixent product
PARIS (Reuters) – Healthcare companies Sanofi and partner Regeneron presented on Tuesday more positive data for their Dupixent product. The companies said new data showed …
French drugmaker Sanofi expects positive boost from currency markets in Q3
PARIS (Reuters) -French drugmaker Sanofi said it expected a positive boost to its third-quarter business results from movements on the currency markets, helped by the …
Analysis-Meagre medicine cabinet leaves Sanofi unloved
By Ludwig Burger FRANKFURT (Reuters) – Sanofi’s recent stock rout underscores the pressure on the French drug maker to redouble its efforts in the hunt …
Sanofi CFO says stock price pummelling grossly overdone
FRANKFURT (Reuters) – Sanofi’s finance chief said on Wednesday that a decline in the French company’s share price in response to litigation threats and a …
China’s Innovent Biologics secures over $300 million investment from Sanofi
(Reuters) – Innovent Biologics Inc said on Friday Paris-based Sanofi SA would invest HK$2.42 billion ($307.88 million) in the biopharmaceutical group to jointly develop two …
Sanofi caps out-of-pocket insulin cost at $35 for uninsured U.S. patients
(Reuters) – French drugmaker Sanofi said on Wednesday uninsured diabetes patients in the United States will pay no more than $35 for 30-day supply of …
Sanofi ordered to compensate French family for epilepsy drug side effects
PARIS – A French court has ordered Sanofi to pay more than 400,000 euros ($416,440) in damages to a family whose child suffered from a …
France’s Sanofi offers 1.5 billion euro bond linked to access to medicine
(Reuters) – French healthcare group Sanofi said it had priced a first sustainability-linked bond issue that will be indexed on access to medicines, and worth …
Sanofi halts new spending on non-essential drugs in Russia and Belarus
PARIS – French drugmaker Sanofi on Wednesday said it would stop immediately any new spending not related to the supply of essential and life-changing medicines …